HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vaccination with Recombinant Microneme Proteins Confers Protection against Experimental Toxoplasmosis in Mice.

Abstract
Toxoplasmosis, a zoonotic disease caused by Toxoplasma gondii, is an important public health problem and veterinary concern. Although there is no vaccine for human toxoplasmosis, many attempts have been made to develop one. Promising vaccine candidates utilize proteins, or their genes, from microneme organelle of T. gondii that are involved in the initial stages of host cell invasion by the parasite. In the present study, we used different recombinant microneme proteins (TgMIC1, TgMIC4, or TgMIC6) or combinations of these proteins (TgMIC1-4 and TgMIC1-4-6) to evaluate the immune response and protection against experimental toxoplasmosis in C57BL/6 mice. Vaccination with recombinant TgMIC1, TgMIC4, or TgMIC6 alone conferred partial protection, as demonstrated by reduced brain cyst burden and mortality rates after challenge. Immunization with TgMIC1-4 or TgMIC1-4-6 vaccines provided the most effective protection, since 70% and 80% of mice, respectively, survived to the acute phase of infection. In addition, these vaccinated mice, in comparison to non-vaccinated ones, showed reduced parasite burden by 59% and 68%, respectively. The protective effect was related to the cellular and humoral immune responses induced by vaccination and included the release of Th1 cytokines IFN-γ and IL-12, antigen-stimulated spleen cell proliferation, and production of antigen-specific serum antibodies. Our results demonstrate that microneme proteins are potential vaccines against T. gondii, since their inoculation prevents or decreases the deleterious effects of the infection.
AuthorsCamila Figueiredo Pinzan, Aline Sardinha-Silva, Fausto Almeida, Livia Lai, Carla Duque Lopes, Elaine Vicente Lourenço, Ademilson Panunto-Castelo, Stephen Matthews, Maria Cristina Roque-Barreira
JournalPloS one (PLoS One) Vol. 10 Issue 11 Pg. e0143087 ( 2015) ISSN: 1932-6203 [Electronic] United States
PMID26575028 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cytokines
  • Protozoan Proteins
  • Protozoan Vaccines
Topics
  • Animals
  • Brain (parasitology)
  • Cells, Cultured
  • Cytokines (blood)
  • Escherichia coli
  • Female
  • Immunity, Cellular
  • Immunity, Humoral
  • Mice, Inbred C57BL
  • Protozoan Proteins (biosynthesis, immunology)
  • Protozoan Vaccines (biosynthesis, immunology)
  • Toxoplasma (immunology)
  • Toxoplasmosis (immunology, parasitology, prevention & control)
  • Vaccination

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: